Loss of imprinting of the insulin-like growth factor 2 gene and risk of colorectal cancer

Current Colorectal Cancer Reports

Volumn 4, Issue 2, 2008, Pages 65-70

  Zhao, Ronghua ^b   Cruz Correa, Marcia ^a  

^a UNIVERSITY OF PUERTO RICO   (Puerto Rico)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 66449126990     PISSN: 15563790     EISSN: 15563804     Source Type: Journal    
DOI: 10.1007/s11888-008-0012-3     Document Type: Article

References (39)

1. Jemal A, Siegel R, Ward E, et al.: Cancer statistics, 2007. CA Cancer J Clin 2007, 57:43-66.
2. Ponz de Leon M: Descriptive epidemiology of hereditary non-polyposis colorectal cancer. Tumori 1996, 82:102-106.
3. Feinberg AP: Genomic imprinting and cancer. In The Genetic Basis of Human Cancer. Edited by Vogelstein B, Kinzler KW. New York: McGraw-Hill; 1998.
4. Morison IM, Ramsay JP, Spencer HG: A census of mammalian imprinting. Trends Genet 2005, 21:457-465.
5. Yuan J, Luo RZ, Fujii S, et al.: Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers. Cancer Res 2003, 63:4174-4180.
6. Astuti D, Latif F, Wagner K, et al.: Epigenetic alteration at the DLK1-GTL2 imprinted domain in human neoplasia: analysis of neuroblastoma, phaeochromocytoma and Wilms' tumour. Br J Cancer 2005, 92:1574-1580.
7. Pedersen IS, Dervan PA, Broderick D, et al.: Frequent loss of imprinting of PEG1/MEST in invasive breast cancer. Cancer Res 1999, 59:5449-5451.
8. Cai YC, Yang GY, Nie Y, et al.: Molecular alterations of p73 in human esophageal squamous cell carcinomas: loss of heterozygosity occurs frequently; loss of imprinting and elevation of p73 expression may be related to defective p53. Carcinogenesis 2000, 21: 683-689.
9. Hibi K, Nakamura H, Hirai A, et al.: Loss of H19 imprinting in esophageal cancer. Cancer Res 1996, 56:480-482.
10. Samani AA, Yakar S, LeRoith D, Brodt P: The role of the IGF system in cancer growth and metastasis: overview and recent insights. Endocr Rev 2007, 28:20-47.
11. Hunt KJ, Toniolo P, Akhmedkhanov A, et al.: Insulin-like growth factor II and colorectal cancer risk in women. Cancer Epidemiol Biomarkers Prev 2002, 11:901-905.
12. Barozzi C, Ravaioli M, D'Errico A, et al.: Relevance of biologic markers in colorectal carcinoma: a comparative study of a broad panel. Cancer 2002, 94:647-657.
13. Probst-Hensch NM, Yuan JM, Stanczyk FZ, et al.: IGF-1, IGF-2 and IGFBP-3 in prediagnostic serum: association with colorectal cancer in a cohort of Chinese men in Shanghai. Br J Cancer 2001, 85:1695-1699.
14. Renehan AG, Jones J, Potten CS, et al.: Elevated serum insulin-like growth factor (IGF)-II and IGF binding protein-2 in patients with colorectal cancer. Br J Cancer 2000, 83:1344-1350.
15. Renehan AG, Painter JE, O'Halloran D, et al.: Circulating insulin-like growth factor II and colorectal adenomas. J Clin Endocrinol Metab 2000, 85:3402-3408.
16. Feinberg AP: Phenotypic plasticity and the epigenetics of human disease. Nature 2007, 447:433-440.
17. Cui H: Loss of imprinting of IGF2 as an epigenetic marker for the risk of human cancer. Dis Markers 2007, 23:105-112.
18. Cui H, Onyango P, Brandenburg S, et al.: Loss of imprinting in colorectal cancer linked to hypomethylation of H19 and IGF2. Cancer Res 2002, 62:6442-6446.
19. Jelinic P, Shaw P: Loss of imprinting and cancer. J Pathol 2007, 211:261-268.
20. Sakatani T, Kaneda A, Iacobuzio-Donahue CA, et al.: Loss of imprinting of Igf2 alters intestinal maturation and tumorigenesis in mice. Science 2005, 307:1976-1978.
21. Cui H, Horon IL, Ohlsson R, et al.: Loss of imprinting in normal tissue of colorectal cancer patients with microsatellite instability. Nat Med 1998, 4:1276-1280.
22. Nishihara S, Hayashida T, Mitsuya K, et al.: Multipoint imprinting analysis in sporadic colorectal cancers with and without microsatellite instability. Int J Oncol 2000, 17:317-322.
23. Takano Y, Shiota G, Kawasaki H: Analysis of genomic imprinting of insulin-like growth factor 2 in colorectal cancer. Oncology 2000, 59:210-216.
24. Zhang FR, He XB, Yang YH, Xie W: The expression and imprinting status of insulin-like growth factor 2 gene in colorectal cancer [in Chinese]. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 2003, 20:31-34.
25. Cui H, Cruz-Correa M, Giardiello F, et al.: Loss of IGF2 imprinting: a potential marker of colorectal cancer risk. Science 2003, 299:1753-1755.
26. Cruz-Correa M, Cui H, Giardiello FM, et al.: Loss of imprinting of insulin growth factor-II gene: a potential heritable biomarker for colon neoplasia predisposition. Gastroenterology 2004, 126:964-970.
27. Woodson K, Flood A, Green L, et al.: Loss of insulin-like growth factor-II imprinting and the presence of screening-detected colorectal adenomas in women. J Natl Cancer Inst 2004, 96:407-410.
28. Liou J, Wu M, Lin J, et al.: Loss of imprinting of insulinlike growth factor II is associated with increased risk of proximal colon cancer. Eur J Cancer 2007, 43:1276-1282.
29. Sasaki J, Konishi F, Kawamura YJ, et al.: Clinicopatho-logical characteristics of colorectal cancers with loss of imprinting of insulin-like growth factor 2. Int J Cancer 2006, 119:80-83.
30. Cruz-Correa M, Zhao R, Oviedo M, et al.: Genotype-phenotype characterization of loss of genomic imprinting of IGF2-positive colorectal cancer [abstract S2014]. Gastroen-terology 2007, 132(Suppl):A299.
31. Ogawa O, Eccles MR, Szeto J, et al.: Relaxation of insulinlike growth factor II gene imprinting implicated in Wilms' tumour. Nature 1993, 362:749-751.
32. Rainier S, Johnson LA, Dobry CJ, et al.: Relaxation of imprinted genes in human cancer. Nature 1993, 362:747-749.
33. Uejima H, Lee MP, Cui H, Feinberg AP: Hot-stop PCR: a simple and general assay for linear quantitation of allele ratios. Nat Genet 2000, 25:375-376. [Erratum appears in Nat Genet 2001, 28:97.]
34. Ronaghi M: Pyrosequencing sheds light on DNA sequencing. Genome Res 2001, 11:3-11.
35. Ohlsson R, Nyström A, Pfeifer-Ohlsson S, et al.: IGF2 is parentally imprinted during human embryogenesis and in the Beckwith-Wiedemann syndrome. Nat Genet 1993, 4:94-97.
36. Adam GI, Cui H, Miller SJ, et al.: Allele-specifc in situ hybridization (ASISH) analysis: a novel technique which resolves differential allelic usage of H19 within the same cell lineage during human placental development. Development 1996, 122:839-847.
37. Ohlsson R, Cui H, He L, et al.: Mosaic allelic insulin-like growth factor 2 expression patterns reveal a link between Wilms' tumorigenesis and epigenetic heterogeneity. Cancer Res 1999, 59:3889-3892.
38. Ohlsson R, Svensson K, Cui H, et al.: Allele-specifc in situ hybridization (ASISH). Methods Mol Biol 2001, 181:153-167.
39. Cui H, Ohlsson R: An improved protocol for purifcation of 35S-labelled oligonucleotide DNA probes for in situ hybridization applications. Trends Genet 1996, 12:506-507.